MyLymphomaTeam

Yes, people can achieve remission even after multiple treatment attempts. While the success rates for second-line treatments are lower than first-line treatments, studies show that about 44% of patients who relapse after R-CHOP can achieve a second remission with additional treatments. Your treatment plan aligns with Show Full Answer

Yes, people can achieve remission even after multiple treatment attempts. While the success rates for second-line treatments are lower than first-line treatments, studies show that about 44% of patients who relapse after R-CHOP can achieve a second remission with additional treatments. Your treatment plan aligns with current medical approaches. For patients who aren't eligible for bone marrow transplant or who have had unsuccessful treatments, options include Polatuzumab vedotin-piiq (Polivy) with bendamustine and rituximab (POLA-BR), which you're starting. Clinical trials, like the allogeneic CAR T-cell therapy you're considering, represent some of the newest advancements in treating resistant DLBCL.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

DLBCL Relapse Rate and Treatment Options

Early vs. Advanced DLBCL: How Are They Treated Differently?